AMYT Market Cap History
Below is a table of the AMYT market cap history going back to 7/8/2020:

Date AMYT Market Cap
7/8/2020102.86M

Also see: AMYT Shares Outstanding History
and AMYT YTD Return
Mouse over chart for data details
7/8/2020
Amryt Pharma is a biopharmaceutical company focused on developing and commercializing therapeutics to treat patients suffering from serious and life-threatening rare disease. Co.'s commercial business comprises two orphan disease products: JUXTAPID®/ LOJUXTA® (lomitapide), which is approved as an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the rare cholesterol disorder, Homozygous Familial Hypercholesterolaemia; and MYALEPT® / MYALEPTA® (metreleptin), which is approved as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy. We show 1 historical shares outstanding datapoints in our AMYT shares outstanding history coverage, used to compute AMYT market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AMYT market cap history over the course of time is important for investors interested in comparing AMYT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AMYT versus a peer is one thing; comparing AMYT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AMYT can fluctuate over the course of history. With this page we aim to empower investors researching AMYT by allowing them to research the AMYT market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AMYT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amryt Pharma (AMYT) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ANCN Market Cap History
ANDA Market Cap History
ANY Market Cap History
ANZU Market Cap History
AONE Market Cap History
APGB Market Cap History
APHA Market Cap History
APSG Market Cap History
APTO Market Cap History
APTV Market Cap History
More Miscellaneous companies »

 

AMYT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.